Rchr
J-GLOBAL ID:201301046448732445   Update date: Jun. 10, 2024

HISATAKE MATSUMOTO

マツモト ヒサタケ | HISATAKE MATSUMOTO
Affiliation and department:
Research field  (4): Molecular biology ,  Genetics ,  Immunology ,  Emergency medicine
Research keywords  (1): Clinical Bioinformatics
Research theme for competitive and other funds  (19):
  • 2023 - 2028 敗血症性脳症の分子病態統合解析と新規生体指標による積極的治療介入方法の提案
  • 2023 - 2026 侵襲時再生治療に関する新規制御因子の解明:ゲノム・エピゲノム統合解析
  • 2023 - 2026 免疫応答バランスからみた熱傷後の免疫不全メカニズムに関する統合的解析
  • 2022 - 2025 網羅的生体分子情報に基づく重症熱傷病態の中心的分子解明と新規治療薬開発
  • 2022 - 2025 Immunomolecular pathogenesis of systemic and local lung immunity in ARDS based on integrated analysis
Show all
Papers (69):
  • Kazuko Uno, Abu Hasan, Emi E Nakayama, Rummana Rahim, Hiromasa Harada, Mitsunori Kaneko, Shoji Hashimoto, Toshio Tanaka, Hisatake Matsumoto, Hitoshi Fujimiya, et al. Predictive biomarkers of COVID-19 prognosis identified in Bangladesh patients and validated in Japanese cohorts. Scientific reports. 2024. 14. 1. 12713-12713
  • Hozaifa Metwally, Maha M Elbrashy, Tatsuhiko Ozawa, Kazuki Okuyama, Jason T White, Janyerkye Tulyeu, Jonas Nørskov Søndergaard, James Badger Wing, Arisa Muratsu, Hisatake Matsumoto, et al. Threonine phosphorylation of STAT1 restricts interferon signaling and promotes innate inflammatory responses. Proceedings of the National Academy of Sciences of the United States of America. 2024. 121. 17. e2402226121
  • Jotaro Tachino, Yuki Togami, Hisatake Matsumoto, Tsunehiro Matsubara, Shigeto Seno, Hiroshi Ogura, Jun Oda. Plasma Proteomics Profile-Based Comparison of Torso Versus Brain Injury: A Prospective Cohort Study. The journal of trauma and acute care surgery. 2024
  • Jotaro Tachino, Shigeto Seno, Hisatake Matsumoto, Tetsuhisa Kitamura, Atsushi Hirayama, Shunichiro Nakao, Yusuke Katayama, Hiroshi Ogura, Jun Oda. Association between tranexamic acid administration and mortality based on the trauma phenotype: a retrospective analysis of a nationwide trauma registry in Japan. Critical care (London, England). 2024. 28. 1. 89-89
  • Risei Fujimoto, Sayaka Oda, Hisatake Matsumoto, Shunichiro Nakao, Kentaro Shimizu, Daisuke Okuzaki, Jun Oda. Longitudinal whole blood transcriptome analysis of a septic shock patient with secondary hemophagocytic syndrome. QJM : monthly journal of the Association of Physicians. 2024
more...
MISC (91):
  • Jumpei Yoshimura, Yuki Togami, Takeshi Ebihara, Hisatake Matsumoto, Yumi Mitsuyama, Fuminori Sugihara, Haruhiko Hirata, Daisuke Okuzaki, Hiroshi Ogura. Classification of patients with COVID-19 by blood RNA endotype: a prospective cohort study. Microbiology spectrum. 2023. 49th. Suppl.1. e0264523-312
  • 松本 寿健. 敗血症のオミックス研究Up-to-date : 新しい分子病態解明と個別化医療への応用-Up-to-date on Omics Research of Sepsis : Elucidation of Novel Molecular Pathogenesis in Sepsis and Its Application to Personalized Medicine-特集 敗血症Up-to-date. ICUとCCU = Japanese journal of intensive care medicine : 集中治療医学. 2023. 47. 11. 715-723
  • 松本寿健. Up-to-date on Omics Research of Sepsis: Elucidation of Novel Molecular Pathogenesis in Sepsis and Its Application to Personalized Medicine. ICUとCCU. 2023. 47. 11. 715-723
  • 舘野 丈太郎, 松本 寿健, 杉原 文徳, 瀬尾 茂人, 奥崎 大介, 北村 哲久, 小向 翔, 木戸 善之, 兒嶋 嵩, 戸上 由貴, et al. 機械学習による新規外傷フェノタイプの同定とプロテオーム解析を用いた病態考察. 日本集中治療医学会雑誌. 2023. 30. Suppl.1. S456-S456
  • 松本寿健, 小倉裕司, 織田順. Disease sub-phenotype and personalized medicine based on comprehensive molecular analysis. 日本集中治療医学会学術集会(Web). 2023. 30. Suppl.1. S345-S345
more...
Patents (4):
Professional career (1):
  • MD-PhD (Osaka University)
Awards (3):
  • 2022 - Roche INFECTIOUS DISEASE AWARD 2022 Significance of interferon signaling based on mRNA-microRNA integration and plasma protein analyses in critically ill COVID-19 patients.
  • 2021 - Roche INFECTIOUS DISEASE AWARD 2022 Combination of WFDC2, CHI3L1, and KRT19 in Plasma Defines a Clinically Useful Molecular Phenotype Associated with Prognosis in Critically Ill COVID-19 Patients
  • 2017/09 - European Shock Society Young investor award Unraveling the role of HIVEP1 in innate immunity and sepsis
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page